U.S. Gas Utilities Stock News

Globus Medical (GMED) stock drew renewed attention after its recent trading move, with the price closing at $81.42. Investors are now reassessing how its business profile and valuation stack up. See our latest analysis for Globus Medical. That latest move sits within a mixed picture. The 7 day share price return of 7.84% contrasts with a 30 day share price decline of 3% and a 90 day share price decline of 9.71%, while the 1 year total shareholder return of 52.33% points to stronger long run...

Hawkins (HWKN) is back in focus after reporting record first quarter revenue of US$315.7 million, a small year over year decline in earnings per share, and a 5% increase in its quarterly dividend. See our latest analysis for Hawkins. The earnings miss and softer EPS appear to be weighing on sentiment, with Hawkins’ share price down 17.2% over the past 90 days and its 1 year total shareholder return down 12.5%. However, 3 and 5 year total shareholder returns remain very strong multiples of the...

Essential Utilities’ board of directors recently declared a higher quarterly cash dividend of US$0.3606 per share, a 5.25% increase, payable on September 1, 2026, to shareholders of record as of August 11, 2026. This dividend increase highlights the company’s ongoing emphasis on returning cash to investors, reinforcing its long-running pattern of consistent payout growth within regulated utilities. With this latest dividend increase underscoring management’s confidence in sustained cash...

Simpson Manufacturing Co., Inc. recently declared a regular quarterly dividend of US$0.30 per share, payable on October 22, 2026 to stockholders of record as of October 1, 2026, and reported second-quarter results with net sales up 6.3% year on year alongside operating margin improvement to 25.2%. The combination of stronger-than-expected quarterly earnings, disciplined pricing, and cost control, plus an expanded US$200 million share repurchase authorization, highlights management’s focus on...

Consumer discretionary stocks sit right in the crosshairs of the latest US data, with slower 1.5% GDP growth in Q2, firm 3.3% core inflation, and solid 2.1% personal spending all pulling in different directions. That mix can reward companies with strong balance sheets and clear demand, while putting pressure on weaker business models. This article focuses on three consumer discretionary stocks from our screener that appear positively exposed to these trends. You will see how each one could...

After a strong three year run for Invesco stock, the valuation picture is not one sided. The intrinsic value estimate from the Excess Returns model points to meaningful upside relative to the share price, while the broader checks and market multiples suggest the stock is closer to fairly priced. Invesco has returned 96.7% over the past three years, which puts extra focus on whether the current price still offers an attractive entry level. The key support for the valuation is the market's...

Photronics stock has more than doubled over the past five years, yet its current valuation sends mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a premium, while market multiples suggest the stock still screens as undervalued. Photronics has returned 104.8% over five years, which puts more attention on whether the current price builds in much of that progress. Expectations for continued demand in its niche of semiconductor manufacturing...

Southwest Airlines (LUV) is back in focus after its second quarter 2026 report, with revenue of US$8,432 million and net income of US$233 million, alongside updated views on its growth and value profile. See our latest analysis for Southwest Airlines. At a share price of US$44.38, Southwest Airlines has seen its 1 month share price return fall 13.99% and its 7 day return decline 6.88%, even after a 90 day share price gain of 17.04% and a 1 year total shareholder return of 47.23%. This...

IMAX Corporation recently reported its second-quarter 2026 results, with revenue rising to US$102.84 million and net income to US$15.4 million, alongside continued execution of a long-running share repurchase program that has retired 26.36% of shares since 2017 for US$262.99 million. The combination of higher earnings per share from continuing operations and steady buybacks highlights how IMAX is pairing operational progress with ongoing capital returns to shareholders. Next, we’ll examine...

OPENLANE (OPLN) drew fresh attention after being highlighted alongside General Motors as an Auto Tires Trucks sector stock that has outperformed its group this year and currently carries a Zacks Rank of #2. See our latest analysis for OPENLANE. At a recent share price of US$40.44, OPENLANE has posted a strong 90 day share price return of 28.63% and a year to date share price return of 38.45%, while its 1 year total shareholder return of 64.06% and 3 year total shareholder return of about 2.6x...

Why Markel Group's Q2 2026 earnings matter for investors Markel Group (MKL) has just released Q2 2026 results, with net income and earnings per share significantly higher than a year ago, supported by stronger insurance underwriting and higher net investment income. The company also reported higher underwriting gross premium volume and operating income in its Markel Insurance segment, alongside continued share repurchases. This combination of operating and capital allocation decisions gives...

Ashland walked into this earnings season with a stock that had quietly climbed over the past quarter, yet the initial reaction today is a mild pullback of about 1%. That muted move masks a quarter that puts profit quality in the spotlight. Adjusted earnings per share reached US$1.02 on revenue of US$497m, while free cash flow came in at US$103m with conversion above 90%. For a specialty chemicals business in which cash generation and margin resilience matter more than headline growth, this...

VICI Properties stock has drifted lower over the past year even as Simply Wall St's Discounted Cash Flow (DCF) intrinsic value estimate and traditional multiples both point to the shares trading at a discount to their assessed worth. Over the past 5 years VICI Properties has delivered a total return of 17.9%, which is positive but not especially strong for a REIT over that timeframe. The key support for the valuation is the cash flow profile from long term leases. The main risk is that...

AI infrastructure and semiconductor stocks have been under heavy selling pressure after Situational Awareness, Leopold Aschenbrenner’s hedge fund, began unwinding leveraged trades and facing margin calls. Forced liquidations in both public and private AI holdings are rippling through the market, which can quickly shift attention back to companies with steadier balance sheets, reliable dividends, and calmer price moves. This article looks at 3 stocks from a Defensive Value Stocks screener that...

Waystar Holding stock has declined 31.2% over the past year, yet the current checks send a mixed message on value as a Discounted Cash Flow (DCF) intrinsic value estimate points to upside while traditional market multiples lean the other way. The share price is down 31.2% over the last 12 months. This puts renewed attention on whether recent weakness has already priced in investor concerns. Growing adoption of Waystar Holding's healthcare payment software and recognition for its connected...

EchoStar (ECHO) has scheduled a conference call for Monday, August 3, 2026, at 12 p.m. Eastern Time to review its second quarter financial results. The company will release these results earlier that day. See our latest analysis for EchoStar. At a share price of $83.89, EchoStar has seen its short term share price return weaken, with the stock down 31.9% over the past 90 days, even though its 1 year total shareholder return is 155.6%, which keeps longer term momentum positive. If EchoStar’s...

Stride, Inc. recently reported preliminary results for the fiscal year ended June 30, 2026, expecting revenue of US$2.52 billion and net income of US$338.2 million, alongside a leadership transition that saw long-time board member Robert Knowling become CEO and Steven Fink assume the role of Chair. The combination of higher expected revenue and profits with an experienced insider stepping into the CEO role could influence how investors assess the company’s operational focus and governance...

Royal Gold has delivered a strong share price gain over the past three years, yet the current valuation picture is more mixed, with the intrinsic value estimate based on a Discounted Cash Flow (DCF) model suggesting the stock trades at a discount while market based multiples look closer to fair value. Royal Gold has returned about 79.5% over three years, which puts more focus on whether the current price still leaves room for attractive long term returns. The company’s cash flow profile and...

Ferrari stock has delivered a strong 89.5% total return over the past 5 years, yet its current valuation screens as expensive on several checks, which raises questions about how much optimism is already built into the price. Over 5 years, Ferrari has returned 89.5%, which puts recent share price weakness over the past year into the context of a longer period of solid gains. Expectations for sustained demand in the high end luxury performance segment can support rich multiples. However, any...

General Dynamics has delivered a 116.0% return over the past 5 years, yet current valuation work suggests the stock may still trade at a discount to its intrinsic value. With fresh contract wins and recent share gains, the key issue for investors is how much of that story is already in the US$380.96 share price. The 116.0% 5 year return signals that General Dynamics has already created substantial value for shareholders, so any further upside may depend on how reliable the current cash flow...

Sarepta Therapeutics (SRPT) is back in focus after the board appointed Michael Severino, M.D., as chief executive and director, with his tenure beginning July 28, 2026, following Douglas Ingram’s departure. See our latest analysis for Sarepta Therapeutics. Despite the leadership change and the recent shelf registration, Sarepta Therapeutics’ 1-day share price return of 0.68% comes after a year-to-date share price decline of 27.10% and a 5-year total shareholder return decline of 76.99%, which...

Liberty Broadband Corporation has reported second-quarter 2026 results showing a net loss of US$2.13 billion, compared with net income of US$383 million a year earlier, with basic and diluted loss per share from continuing operations of US$14.86 versus earnings of US$2.49 previously. For the first half of 2026, the swing from net income of US$651 million to a net loss of US$1.92 billion, and from earnings per share of US$4.13 to a loss of US$13.44, raises questions about how such a sharp...

ICF International (ICFI) is back in focus after its AI enabled DevSecOps knowledge fabric achieved “Awardable” status in the Department of War’s Platform One marketplace, supported by its CMMC Level 2 cybersecurity certification. See our latest analysis for ICF International. The recent AI enabled contract momentum comes as ICF International’s share price shows improving short term sentiment, with a 7 day share price return of 8.32% and 90 day share price return of 15.87%, while the 3 year...

Moderna (MRNA) has been in focus after its recent quarter showed significant year over year revenue growth that beat market expectations, along with fresh European approvals and progress in late stage pipeline programs. See our latest analysis for Moderna. Even with the recent pullback, with the 1 month share price return down 21.82% and the 7 day share price return down 6.17%, Moderna still shows strong year to date share price momentum of 76.57% and a 1 year total shareholder return of...